Table 3.
Mycotoxin concentrations in Swedish urine samples determined by application of the DaS (Warensjö Lemming et al. 2020) and the DUS method (n = 91)
| DH-CIT | DON | OTA | ||||
|---|---|---|---|---|---|---|
| DUS | DaS | DUS | DaSb | DUS | DaS | |
| LOQ (ng/mL) | 0.06 | 0.70 | 3.0 | 5.6 | 0.013 | 0.030 |
| Positive samples % (n) | 54.9 (50) | 15.4 (14) | 75.8 (69) | 54.9 (50) | 81.3 (74) | 1.1 (1) |
| Quantitated samples % (n) | 37.4 (34) | 0 (0) | 70.3 (64) | 39.6 (36) | 68.1 (62) | 0 (0) |
| Meana (ng/mL) | 0.29 | – | 21 | 25 | 0.058 | – |
| Mediana (ng/mL) | 0.17 | – | 12 | 12 | 0.040 | – |
| Maximum (ng/mL) | 0.97 | – | 136 | 139 | 0.434 | – |
| SD quantitated samples (ng/mL) | 0.25 | – | 26 | 31 | 0.064 | – |
SD standard deviation
aMeans and median were calculated from samples with mycotoxin concentrations > LOQ
bTotal DON was calculated from the sum of DON and DON-GlcA